Stockhub

4D Molecular Therapeutics, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 August 2022

11 August 2022

28 July 2022

  • curprev 19:4819:48, 28 July 2022‎ Chris talk contribs‎ 1,924 bytes +1,924‎ Created page with "4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/4D_Molecular_Therapeutics,_Inc.’